Clinical trial
Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally…
NCT00061659 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00061659 |
|---|---|
| Title | Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma |
| Official title | A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Soft Tissue |
| Intervention type | Drug |
| Interventions | ABT-510 - Thrombospondin-1 mimetic |
| Enrollment | 88 |
| Start date | May 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Jun 4, 2003 |
| Last update posted | Nov 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: